(19)

(11)

EP 4 739 301 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24754437.2 (22) Date of filing: 03.07.2024

(51) International Patent Classification (IPC):  A61K 31/20(2006.01) A61P 1/16(2006.01) A61K 38/26(2006.01) (52) Cooperative Patent Classification (CPC): A61K 38/26; A61K 31/20; A61P 1/16; A61K 45/06   C-Sets: A61K 31/20, A61K 2300/00; A61K 38/26, A61K 2300/00; (86) International application number: PCT/US2024/036741 (87) International publication number: WO 2025/014754 (16.01.2025 Gazette 2025/03)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 07.07.2023 US 202363512395 P (71) Applicant: Esperion Therapeutics, Inc. Ann Arbor, MI 48108 (US)	(72) Inventors: PINKOSKY, Stephen L. Plymouth, Michigan 48170 (US) STEINBERG, Gregory R. Ancaster, Ontario L9G4M2 (CA) DESJARDINS, Eric Marc-Andre Thornhill, Ontario L3T2L8 (CA) (74) Representative: Mewburn Ellis LLP  Aurora Building Counterslip Bristol BS1 6BX Bristol BS1 6BX (GB)